The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Correlation of T-cell inflamed phenotype with mesenchymal subtype, expression of PD-L1, and other immune checkpoints in head and neck cancer.
Vassiliki Saloura
No relevant relationships to disclose
Zhixiang Zuo
No relevant relationships to disclose
Hartmut Koeppen
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Michaela K. Keck
No relevant relationships to disclose
Arun Khattri
No relevant relationships to disclose
Marigold Boe
No relevant relationships to disclose
Priti S. Hegde
Employment or Leadership Position - Genentech
Yuanyuan Xiao
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
Yusuke Nakamura
No relevant relationships to disclose
Everett E. Vokes
Consultant or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis; Synta; VentiRx
Jonas A. De Souza
No relevant relationships to disclose
Victoria Meucci Villaflor
No relevant relationships to disclose
Justin Paul Kline
No relevant relationships to disclose
Thomas Gajewski
Research Funding - Merck
Mark W. Lingen
No relevant relationships to disclose
Marcin Kowanetz
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Tanguy Y. Seiwert
Consultant or Advisory Role - Bayer/Onyx; Boehringer Ingelheim; Novartis
Research Funding - Boehringer Ingelheim; Genentech